Distinct responses of COL17A1 nonsense variants to readthrough drugs and NOG as a novel enhancer in junctional epidermolysis bullosa

Molecular Therapy: Nucleic Acids · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles